Join us on the latest episode of Global Market Bulletin TV, where host Leyla Gulen engages in a captivating discussion with Cryoport’s top executives, Chief Scientific Officer Mark W. Sawicki, Ph.D., and Vice President of Corporate Development Thomas J. Heinzen. This special interview delves into the groundbreaking work that positions Cryoport as a global frontrunner in temperature-controlled supply chain solutions for the life sciences sector.
Cryoport’s 2022 Milestones
During the conversation, Mr. Sawicki and Mr. Heinzen proudly highlight Cryoport’s remarkable achievements in 2022, showcasing a significant revenue milestone of $237 million, marking a 27% increase in commercial income. The company’s pivotal role in the life sciences industry is further underscored by its support of 654 global clinical trials and 10 commercial therapies, illustrating its critical impact on global health advancements.
Strategic Partnership with Syneos Health
The Cryoport executives also shed light on their recent strategic partnership with Syneos Health, an integrated biopharmaceutical solutions organization. This collaboration is designed to accelerate customer success, combining Syneos Health’s comprehensive solutions with Cryoport’s specialized temperature-controlled logistics to enhance the delivery of life-saving therapies.
Meet the Guests
Mark W. Sawicki, Ph.D., brings over 15 years of business development and sales management expertise to his role at Cryoport. His impressive track record includes substantial contributions to the success of AAIPharma Services Corporation/Cambridge Major Laboratories Inc., among others. Dr. Sawicki’s extensive research in Immunology & Oncology, coupled with his published works, make him a distinguished figure in the scientific community.
Thomas J. Heinzen has a robust background in investment banking and equity trading, spanning more than two decades. Before joining Cryoport, Heinzen held several executive positions, showcasing his leadership and financial acumen. As the current Chairman for Spire Credit Union and holder of multiple security licenses, Heinzen’s expertise significantly contributes to Cryoport’s strategic development.
About Cryoport
Cryoport stands as the trusted partner for life sciences organizations in need of reliable temperature-controlled logistics solutions. The company’s innovative offerings, including the Cryoport Express® liquid nitrogen dry vapor shippers and the Smartpak II® condition monitoring system, are complemented by its advanced geo-sensing technology. Cryoport’s commitment to excellence is evident through its 24/7 customer support and the Cryoportal® logistics management platform, ensuring the safe and efficient delivery of vital therapies.
To learn more about how Cryoport is revolutionizing the supply chain for life sciences, visit their official website at Cryoport’s Official Website.
Don’t miss this insightful episode on Global Market Bulletin TV, as we explore the future of life sciences logistics with Cryoport’s visionary leaders.
